Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2025-12-25 @ 4:08 AM
NCT ID:
NCT00930020
Eligibility Criteria:
Inclusion Criteria:
* Singapore citizens or permanent residents
* Age range between 21 to 80 years
* NIHSS equal or more than 5 but less than 22 at time of admission
* Clinical diagnosis of acute ischemic stroke according to WHO criteria
* Onset of stroke between 3 to 48 hours prior to start of treatment
* Must have a working telephone line
Exclusion Criteria:
* Long term residents of Institutions and Nursing homes
* Patients with significant baseline cognitive dysfunction
* Patients with hemorrhagic stroke
* Pre-stroke MRS more than 1
* Evidence of other disease of the CNS (i.e., brain tumor, CNS infections)
* Known allergic response to tetracycline
* Acute or Chronic renal failure
* Hepatitis or liver disease
* Pre-existing infectious disease requiring antibiotics
* Receipts of IV rTPA
* Participation in another clinical trial in the preceding 3 months
* Unable or unwilling to provide inform consent
* Unwilling to return for frequent clinic visits
* Geographic or social factors making the study participation impractical
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
80 Years
Study:
NCT00930020
Study Brief:
Protocol Section:
NCT00930020